A new case study documents six months of complete pain relief in an 80-year-old man with arthritis, achieved without ...

The U.S. Food and Drug Administration has approved Deucravacitinib (Sotyktu) for the treatment of adults with Psoriatic Arthritis. This oral drug is a selective TYK2 inhibitor and had ...

In phase 3 clinical trials, tildrakizumab treatment was associated with significantly higher ACR20 response rates at week 24 compared with placebo.

Rogers recommended gentle movement as a key component of managing chronic joint pain, cautioning against both overexertion ...

Some 120 million to 130 million Americans — nearly half of US adults — are believed to take an over-the-counter pain reliever ...

You swing your legs out of bed in the morning, and your knees protest like rusty hinges. Those first few steps feel sore, ...